Literature DB >> 19166657

Small-duct primary sclerosing cholangitis.

Einar Björnsson1.   

Abstract

Patients with cholestatic liver tests and typical histologic features of primary sclerosing cholangitis (PSC) but a normal cholangiogram have been identified as having small-duct PSC. This subgroup of PSC has been less well characterized than the classic large-duct form. Some patients characterized as having small-duct PSC develop cholangiographic features of PSC during follow-up. Three papers published in 2002 on small-duct PSC patients suggested a better prognosis in patients with small-duct PSC than in those with large-duct PSC. However, these studies included a limited number of patients and had a short follow-up. A combined cohort of these patients with a prolonged follow-up recently confirmed these previous observations. However, some patients will suffer from liver-related mortality or will need to undergo liver transplantation. Recurrence of small-duct PSC after liver transplantation has been reported. Cholangiocarcinoma, the most feared complication of PSC, has not been described in a patient with small-duct PSC without progression first to large-duct PSC.

Entities:  

Mesh:

Year:  2009        PMID: 19166657     DOI: 10.1007/s11894-009-0006-6

Source DB:  PubMed          Journal:  Curr Gastroenterol Rep        ISSN: 1522-8037


  33 in total

1.  Natural history and outcome in 32 Swedish patients with small duct primary sclerosing cholangitis (PSC).

Authors:  Ulrika Broomé; Hans Glaumann; Eva Lindstöm; Lars Lööf; Sven Almer; Hanne Prytz; Hanna Sandberg-Gertzén; Stefan Lindgren; Frans-Thomas Fork; Gunnar Järnerot; Rolf Olsson
Journal:  J Hepatol       Date:  2002-05       Impact factor: 25.083

2.  Small-duct primary sclerosing cholangitis: a long-term follow-up study.

Authors:  Paul Angulo; Yaakov Maor-Kendler; Keith D Lindor
Journal:  Hepatology       Date:  2002-06       Impact factor: 17.425

3.  Spontaneous course of symptoms in primary sclerosing cholangitis: relationships with biochemical and histological features.

Authors:  R Olsson; U Broomé; A Danielsson; I Hägerstrand; G Järnerot; L Lööf; H Prytz; B O Rydén
Journal:  Hepatogastroenterology       Date:  1999 Jan-Feb

4.  Primary sclerosing cholangitis: a long-term follow-up study.

Authors:  E Aadland; E Schrumpf; O Fausa; K Elgjo; A Heilo; T Aakhus; E Gjone
Journal:  Scand J Gastroenterol       Date:  1987-08       Impact factor: 2.423

5.  International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis.

Authors:  F Alvarez; P A Berg; F B Bianchi; L Bianchi; A K Burroughs; E L Cancado; R W Chapman; W G Cooksley; A J Czaja; V J Desmet; P T Donaldson; A L Eddleston; L Fainboim; J Heathcote; J C Homberg; J H Hoofnagle; S Kakumu; E L Krawitt; I R Mackay; R N MacSween; W C Maddrey; M P Manns; I G McFarlane; K H Meyer zum Büschenfelde; M Zeniya
Journal:  J Hepatol       Date:  1999-11       Impact factor: 25.083

6.  Morphologic features of chronic hepatitis associated with primary sclerosing cholangitis and chronic ulcerative colitis.

Authors:  J Ludwig; S S Barham; N F LaRusso; L R Elveback; R H Wiesner; J T McCall
Journal:  Hepatology       Date:  1981 Nov-Dec       Impact factor: 17.425

7.  Primary sclerosing cholangitis in Japan--analysis of 192 cases.

Authors:  H Takikawa; T Manabe
Journal:  J Gastroenterol       Date:  1997-02       Impact factor: 7.527

8.  Impact of inflammatory bowel disease and ursodeoxycholic acid therapy on small-duct primary sclerosing cholangitis.

Authors:  Phunchai Charatcharoenwitthaya; Paul Angulo; Felicity B Enders; Keith D Lindor
Journal:  Hepatology       Date:  2008-01       Impact factor: 17.425

9.  High prevalence of small duct primary sclerosing cholangitis among patients with overlapping autoimmune hepatitis and primary sclerosing cholangitis.

Authors:  Rolf Olsson; Hans Glaumann; Sven Almer; Ulrika Broomé; Barbro Lebrun; Annika Bergquist; Einar Björnsson; Hanne Prytz; Ake Danielsson; Stefan Lindgren
Journal:  Eur J Intern Med       Date:  2008-10-11       Impact factor: 4.487

10.  Primary sclerosing cholangitis: natural history, prognostic factors and survival analysis.

Authors:  R H Wiesner; P M Grambsch; E R Dickson; J Ludwig; R L MacCarty; E B Hunter; T R Fleming; L D Fisher; S J Beaver; N F LaRusso
Journal:  Hepatology       Date:  1989-10       Impact factor: 17.425

View more
  8 in total

1.  A morphometric study of the hepatic arterioles in end-stage primary sclerosing cholangitis.

Authors:  M Isabel Fiel; Hamid R Sima; Amirabbas Azarian; Thomas D Schiano
Journal:  Virchows Arch       Date:  2014-11-22       Impact factor: 4.064

Review 2.  The IBD and PSC Phenotypes of PSC-IBD.

Authors:  Amanda Ricciuto; Binita M Kamath; Anne M Griffiths
Journal:  Curr Gastroenterol Rep       Date:  2018-03-28

Review 3.  Latest and emerging therapies for primary biliary cirrhosis and primary sclerosing cholangitis.

Authors:  Claudia O Zein; Keith D Lindor
Journal:  Curr Gastroenterol Rep       Date:  2010-02

Review 4.  Primary sclerosing cholangitis: diagnosis, prognosis, and management.

Authors:  Siddharth Singh; Jayant A Talwalkar
Journal:  Clin Gastroenterol Hepatol       Date:  2013-02-27       Impact factor: 11.382

5.  Small duct primary sclerosing cholangitis without inflammatory bowel disease is genetically different from large duct disease.

Authors:  Sigrid Naess; Einar Björnsson; Jarl A Anmarkrud; Said Al Mamari; Brian D Juran; Konstantinos N Lazaridis; Roger Chapman; Annika Bergquist; Espen Melum; Steven G E Marsh; Erik Schrumpf; Benedicte A Lie; Kirsten M Boberg; Tom H Karlsen; Johannes R Hov
Journal:  Liver Int       Date:  2014-03-07       Impact factor: 5.828

6.  Analysis of the Clinical Course of Primary Sclerosing Cholangitis in Paediatric Population-Single Center Study.

Authors:  Sabina Wiecek; Alicja Wojtyniak; Barbara Pindur; Magdalena Machnikowska-Sokołowska; Katarzyna Gruszczyńska; Urszula Grzybowska-Chlebowczyk
Journal:  Medicina (Kaunas)       Date:  2021-06-27       Impact factor: 2.430

7.  Adult idiopathic cholestasis: a condition more common in the Canadian Inuit?

Authors:  Gerald Y Minuk; Galia Pollock; Julia Uhanova
Journal:  Int J Circumpolar Health       Date:  2017       Impact factor: 1.228

Review 8.  Pathogenesis and clinical spectrum of primary sclerosing cholangitis.

Authors:  Neelam G Gidwaney; Swati Pawa; Kiron M Das
Journal:  World J Gastroenterol       Date:  2017-04-14       Impact factor: 5.742

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.